6 Dimensions Capital-backed neuromodulation technology developer Neuspera closed a $65m round while gene therapy developer Coave Therapeutics hiked its latest round to $39m.
Funding Neuspera Medical, a US-based neuromodulation system developer backed by pharmaceutical firm WuXi AppTec, completed a $65m series C round yesterday that was co-led by Vertex Ventures and Treo Ventures and which included Action Potential Venture Capital and Windham Venture Partners. The company had previously raised about $36m, closing a $26m series B round in…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.